HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 94 filers reported holding HARPOON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $968 | -3.2% | 1,363 | -5.1% | 0.00% | – |
| Q1 2023 | $1,000 | +99900.0% | 1,436 | +5.4% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 1,363 | -45.6% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 2,504 | +39.8% | 0.00% | – |
| Q2 2022 | $3,000 | -99.7% | 1,791 | -99.1% | 0.00% | – |
| Q1 2022 | $996,000 | -35.5% | 200,349 | -2.0% | 0.00% | – |
| Q4 2021 | $1,544,000 | -8.8% | 204,437 | -4.6% | 0.00% | – |
| Q3 2021 | $1,693,000 | -46.5% | 214,287 | -6.1% | 0.00% | – |
| Q2 2021 | $3,167,000 | -36.9% | 228,316 | -4.9% | 0.00% | -100.0% |
| Q1 2021 | $5,022,000 | +255.2% | 240,085 | +182.1% | 0.00% | – |
| Q4 2020 | $1,414,000 | +2144.4% | 85,103 | +2058.9% | 0.00% | – |
| Q3 2020 | $63,000 | -51.5% | 3,942 | -49.9% | 0.00% | – |
| Q2 2020 | $130,000 | +381.5% | 7,865 | +234.4% | 0.00% | – |
| Q1 2020 | $27,000 | -22.9% | 2,352 | -1.3% | 0.00% | – |
| Q4 2019 | $35,000 | +9.4% | 2,382 | +0.2% | 0.00% | – |
| Q3 2019 | $32,000 | +60.0% | 2,378 | +46.0% | 0.00% | – |
| Q2 2019 | $20,000 | +233.3% | 1,629 | +161.5% | 0.00% | – |
| Q1 2019 | $6,000 | – | 623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |